Back to Journals » Clinical Ophthalmology » Volume 5

Bilateral presumed astrocytic hamartomas in a patient with retinitis pigmentosa

Authors Kinori M, Moroz I, Rotenstreich Y, Yonath H, Didi Fabian I, Vishnevskia-Dai V

Published 24 November 2011 Volume 2011:5 Pages 1663—1665


Review by Single anonymous peer review

Peer reviewer comments 3

Michael Kinori1, Iris Moroz1,2, Ygal Rotenstreich1,2, Hagith Yonath2,3, Ido Didi Fabian1, Vicktoria Vishnevskia-Dai1,2
Department of Ophthalmology, Chaim Sheba Medical Center, Tel Hashomer, Israel; 2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; 3Danek Gertner Genetic Institute and Internal Medicine A, Chaim Sheba Medical Center, Tel Hashomer, Israel

Abstract: Retinal astrocytic hamartomas are benign intraocular tumors classically associated with phacomatoses. Their appearance in isolation is rare. An association between astrocytic hamartomas and retinitis pigmentosa (RP) has been described previously, but controversy still exists regarding the precise nature of these lesions in RP patients. The authors present a case report of a 24-year-old male with RP and multiple bilateral lesions clinically consistent with retinal astrocytic hamartomas. Optical coherence tomography revealed multiple bilateral hyper-reflective intraretinal masses, loss of retinal architecture, intralesional calcifications, and prominent optical posterior shadowing. Comprehensive systemic evaluation was negative for phacomatoses. However, given that a biopsy was not performed, the diagnosis of optic nerve head drusen could not be excluded.

Keywords: giant drusen, optic nerve head drusen, optical coherence tomography, intraocular tumor

Creative Commons License © 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.